Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med. 2014;370:640-649.
Vandenplas O, Wiszniewska M, Raulf M, et al. EAACI position paper: irritant-induced asthma. Allergy. 2014;69:1141-1153.
Tarlo SM, Balmes J, Balkissoon R, et al. Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement. Chest. 2008;134(3 suppl):1S-41S.
Baur X, Bakehe P. Allergens causing occupational asthma: an evidence-based evaluation of the literature. Int Arch Occup Environ Health. 2014;87:339-363.
Quirce S. Eosinophilic bronchitis in the workplace. Curr Opin Allergy Clin Immunol. 2004;4:87-91.
Baatjies R, Meijster T, Heederik D, et al. Effectiveness of interventions to reduce flour dust exposures in supermarket bakeries in South Africa. Occup Environ Med. 2014;71:811-818.
Baur X. A compendium of causative agents of occupational asthma. J Occup Med Toxicol. 2013;8:15.
Vandenplas O, Ghezzo H, Munoz X, et al. What are the questionnaire items most useful in identifying subjects with occupational asthma? Eur Respir J. 2005;26:1056-1063.
Beach J, Russell K, Blitz S, et al. A systematic review of the diagnosis of occupational asthma. Chest. 2007;131:569-578.
Vandenplas O, Suojalehto H, Aasen TB, et al. Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement. Eur Respir J. 2014;43:1573-1587.
Beach J, Rowe BH, Blitz S, et al. Diagnosis and management of work-related asthma. Evid Rep Technol Assess (Summ). 2005;129:1-8.
Balmes J, Becklake M, Blanc P, et al. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med. 2003;167:787-797.
Baur X, Sigsgaard T, Aasen TB, et al; ERS Task Force on the Management of Work-related Asthma. Guidelines for the management of work-related asthma. Eur Respir J. 2012;39:529-545.
Ameille J, Descatha A. Outcome of occupational asthma. Curr Opin Allergy Clin Immunol. 2005;5:125-128.
Vandenplas O, Henneberger PK. Socioeconomic outcomes in work-exacerbated asthma. Curr Opin Allergy Clin Immunol. 2007;7:236-241.
CDC: work-related asthma
1. Tarlo SM, Liss GM. Occupational asthma: an approach to diagnosis and management. CMAJ. 2003;168:867-871.
2. Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med. 2014;370:640-649.
3. Malo JL, Vandenplas O. Definitions and classification of work-related asthma. Immunol Allergy Clin North Am. 2011;31:645-662.
4. Vandenplas O, Wiszniewska M, Raulf M, et al. EAACI position paper: irritant-induced asthma. Allergy. 2014;69:1141-1153.
5. Mapp CE, Boschetto P, Maestrelli P, et al. Occupational asthma. Am J Respir Crit Care Med. 2005;172:280-305.
6. Torén K, Blanc PD. Asthma caused by occupational exposures is common: a systematic analysis of estimates of the population-attributable fraction. BMC Pulm Med. 2009;9:7.
7. Jeebhay MF, Quirce S. Occupational asthma in the developing and industrialised world: a review. Int J Tuberc Lung Dis. 2007;11:122-133.
8. Le Moual N, Carsin AE, Siroux V, et al. Occupational exposures and uncontrolled adult-onset asthma in the European Community Respiratory Health Survey II. Eur Respir J. 2014;43:374-386.
9. McDonald JC, Chen Y, Zekveld C, et al. Incidence by occupation and industry of acute work related respiratory diseases in the UK, 1992-2001. Occup Environ Med. 2005;62:836-842.
10. Kogevinas M, Zock JP, Jarvis D, et al. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet. 2007;370:336-341.
11. Karjalainen A, Kurppa K, Martikainen R, et al. Work is related to a substantial portion of adult-onset asthma incidence in the Finnish population. Am J Respir Crit Care Med. 2001;164:565-568.
12. Stocks SJ, McNamee R, van der Molen HF, et al. Trends in incidence of occupational asthma, contact dermatitis, noise-induced hearing loss, carpal tunnel syndrome and upper limb musculoskeletal disorders in European countries from 2000 to 2012. Occup Environ Med. 2015;72:294-303.
13. Gautrin D, Infante-Rivard C, Ghezzo H, et al. Incidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals. Am J Respir Crit Care Med. 2001;163:899-904.
14. Vizcaya D, Mirabelli MC, Gimeno D, et al. Cleaning products and short-term respiratory effects among female cleaners with asthma. Occup Environ Med. 2015;72:757-763.
15. Tarlo SM, Liss GM, Yeung KS. Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures. Occup Environ Med. 2002;59:58-62.
16. Le Moual N, Kennedy SM, Kauffmann F. Occupational exposures and asthma in 14,000 adults from the general population. Am J Epidemiol. 2004;160:1108-1116.
17. Malo JL, Ghezzo H, D'Aquino C, et al. Natural history of occupational asthma: relevance of type of agent and other factors in the rate of development of symptoms in affected subjects. J Allergy Clin Immunol. 1992;90:937-944.
18. Tarlo SM, Easty A, Eubanks K, et al. Outcomes of a natural rubber latex control program in an Ontario teaching hospital. J Allergy Clin Immunol. 2001;108:628-633.
19. Wai Y, Tarlo SM. Occupational lung disease in women. In: Buist S, Mapp CE, ed. Respiratory diseases in women. European Respiratory Monograph, vol 8, no 25. Lausanne, Switzerland: European Respiratory Society; 2003:131-146.
20. Bernstein IL, Chan-Yeung M, Malo JL, et al, eds. Asthma in the workplace, and related conditions. New York, NY: Taylor & Francis; 2006.
21. Yucesoy B, Kaufman KM, Lummus ZL, et al. Genome-wide association study identifies novel loci associated with diisocyanate-induced occupational asthma. Toxicol Sci. 2015;146:192-201.
22. Tarlo SM, Balmes J, Balkissoon R, et al. Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement. Chest. 2008;134(3 suppl):1S-41S.
23. Baur X, Bakehe P. Allergens causing occupational asthma: an evidence-based evaluation of the literature. Int Arch Occup Environ Health. 2014;87:339-363.
24. Cartier A. New causes of immunologic occupational asthma, 2012-2014. Curr Opin Allergy Clin Immunol. 2015;15:117-123.
25. Dumas O, Laurent E, Bousquet J, et al. Occupational irritants and asthma: an Estonian cross-sectional study of 34,000 adults. Eur Respir J. 2014;44:647-656.
26. Quirce S. Eosinophilic bronchitis in the workplace. Curr Opin Allergy Clin Immunol. 2004;4:87-91.
27. Girard F, Chaboillez S, Cartier A, et al. An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med. 2004;170:845-850.
28. Baur X. Are we closer to developing threshold limit values for allergens in the workplace? Ann Allergy Asthma Immunol. 2003;90(5 suppl 2):11-18.
29. Baatjies R, Meijster T, Heederik D, et al. Effectiveness of interventions to reduce flour dust exposures in supermarket bakeries in South Africa. Occup Environ Med. 2014;71:811-818.
30. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-968.
31. Crapo RO, Casaburi R, Coates AL, et al. American Thoracic Society: guidelines for methacholine and exercise challenge testing - 1999. Am J Respir Crit Care Med. 2000;161:309-329.
32. Baur X. A compendium of causative agents of occupational asthma. J Occup Med Toxicol. 2013;8:15.
33. Raulf M, Buters J, Chapman M, et al; European Academy of Allergy and Clinical Immunology. Monitoring of occupational and environmental aeroallergens-EAACI Position Paper. Allergy. 2014;69:1280-1299.
34. Rosenman KD, Beckett WS. Web based listing of agents associated with new onset work-related asthma. Respir Med. 2015;109:625-631.
35. Vandenplas O, Ghezzo H, Munoz X, et al. What are the questionnaire items most useful in identifying subjects with occupational asthma? Eur Respir J. 2005;26:1056-1063.
36. Malo JL, Ghezzo H, L'Archeveque J, et al. Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis. 1991 Mar;143(3):528-32.
37. Beach J, Russell K, Blitz S, et al. A systematic review of the diagnosis of occupational asthma. Chest. 2007;131:569-578.
38. Vandenplas O, Suojalehto H, Aasen TB, et al. Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement. Eur Respir J. 2014;43:1573-1587.
39. Beach J, Rowe BH, Blitz S, et al. Diagnosis and management of work-related asthma. Evid Rep Technol Assess (Summ). 2005;129:1-8.
40. Liss GM, Tarlo SM. Peak expiratory flow rates in possible occupational asthma. Chest. 1991;100:63-69.
41. Perrin B, Lagier F, L'Archeveque J, et al. Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Eur Respir J. 1992;5:40-48.
42. Cote J, Kennedy S, Chan-Yeung M. Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma. J Allergy Clin Immunol. 1990;85:592-598.
43. Pralong JA, Lemière C, Rochat T, et al. Predictive value of nonspecific bronchial responsiveness in occupational asthma. J Allergy Clin Immunol. 2016;137:412-416.
44. Piipari R, Piirila P, Keskinen H, et al. Exhaled nitric oxide in specific challenge tests to assess occupational asthma. Eur Respir J. 2002;20:1532-1537.
45. Florentin A, Acouetey DS, Remen T, et al. Exhaled nitric oxide and screening for occupational asthma in two at-risk sectors: bakery and hairdressing. Int J Tuberc Lung Dis. 2014;18:744-750.
46. Bernstein JA, Bernstein DI, Stauder T, et al. A cross-sectional survey of sensitization to Aspergillus oryzae-derived lactase in pharmaceutical workers. J Allergy Clin Immunol. 1999;103:1153-1157.
47. Nicholson PJ, Cullinan P, Burge PS, et al. Occupational asthma: prevention, identification & management: systematic review & recommendations. London: British Occupational Health Research Foundation; 2010.
48. Chan-Yeung M, Malo JL, Tarlo SM, et al. American Thoracic Society workshop: Proceedings of the First Jack Pepys Occupational Asthma Symposium. Am J Respir Crit Care Med. 2003;167:450-471.
49. Chiry S, Cartier A, Malo JL, et al. Comparison of peak expiratory flow variability between workers with work-exacerbated asthma and occupational asthma. Chest. 2007;132:483-488.
50. Vandenplas O, Malo JL. Inhalation challenges with agents causing occupational asthma. Eur Respir J. 1997;10:2612-2629.
51. Henneberger PK. Work-exacerbated asthma. Curr Opin Allergy Clin Immunol. 2007;7:146-151.
52. Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax. 2002;57:178-182.
53. Fishwick D, Bradshaw L, Henson M, et al. Occupational asthma: an assessment of diagnostic agreement between physicians. Occup Environ Med. 2007;64:185-190.
54. Balmes J, Becklake M, Blanc P, et al. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med. 2003;167:787-797.
55. Andrianopoulos MV, Gallivan GJ, Gallivan KH. PVCM, PVCD, EPL, and irritable larynx syndrome: what are we talking about and how do we treat it? J Voice. 2000;14:607-618.
56. Vlahakis NE, Patel AM, Maragos NE, et al. Diagnosis of vocal cord dysfunction: the utility of spirometry and plethysmography. Chest. 2002;122:2246-2249.
57. Global Initiative for Asthma. 2018 GINA report: global strategy for asthma management and prevention. March 2018 [internet publication].
58. Baur X, Sigsgaard T, Aasen TB, et al; ERS Task Force on the Management of Work-related Asthma. Guidelines for the management of work-related asthma. Eur Respir J. 2012;39:529-545.
59. Vandenplas O, Dressel H, Nowak D, et al; ERS Task Force on the Management of Work-related Asthma. What is the optimal management option for occupational asthma? Eur Respir Rev. 2012;21:97-104.
60. Ameille J, Descatha A. Outcome of occupational asthma. Curr Opin Allergy Clin Immunol. 2005;5:125-128.
61. Vandenplas O, Henneberger PK. Socioeconomic outcomes in work-exacerbated asthma. Curr Opin Allergy Clin Immunol. 2007;7:236-241.
62. de Groene GJ, Pal TM, Beach J, et al. Workplace interventions for treatment of occupational asthma. Cochrane Database Syst Rev. 2011;(5):CD006308.
63. Vandenplas O, Dressel H, Wilken D, et al. Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence. Eur Respir J. 2011;38:804-811.
64. Maestrelli P, De Marzo N, Saetta M, et al. Effects of inhaled beclomethasone on airway responsiveness in occupational asthma: placebo-controlled study of subjects sensitized to toluene diisocyanate. Am Rev Respir Dis. 1993;148:407-412.
65. Malo JL, Cartie A, Cote J, et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. Am J Respir Crit Care Med. 1996;153:953-960.
66. Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest. 1985;88:376-384.
67. Lemière C, To T, de Olim C, et al. Outcome of work-related asthma exacerbations in Quebec and Ontario. Eur Respir J. 2015;45:266-268.
68. Rachiotis, G, Savani, R, Brant, A, et al. Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax. 2007;62:147-152.
69. Moscato G, Pala g, Boillat MA, et al. EAACI position paper: prevention of work-related respiratory allergies among pre-apprentices or apprentices and young workers. Allergy. 2011;66:1164-1173.
70. Tarlo SM, Malo JL; Fourth Jack Pepys Workshop on Asthma in the Workplace Participants. An official American Thoracic Society proceedings: work-related asthma and airway diseases. Presentations and discussion from the Fourth Jack Pepys Workshop on Asthma in the Workplace. Ann Am Thorac Soc. 2013;10:S17-S24.
71. Nicholson PJ, Mayho GV, Roomes D, et al. Health surveillance of workers exposed to laboratory animal allergens. Occup Med (Lond). 2010;60:591-597.
72. Ribeiro M, Tarlo SM, Czyrka A, et al. Diisocyanate and non-diisocyanate sensitizer-induced occupational asthma frequency during 2003 to 2007 in Ontario, Canada. J Occup Environ Med. 2014;56:1001-1007.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台